A detailed history of Private Advisor Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Private Advisor Group, LLC holds 849,585 shares of PFE stock, worth $22.6 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
849,585
Previous 735,962 15.44%
Holding current value
$22.6 Million
Previous $20.6 Million 19.4%
% of portfolio
0.16%
Previous 0.14%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

BUY
$27.7 - $31.39 $3.15 Million - $3.57 Million
113,623 Added 15.44%
849,585 $24.6 Million
Q2 2024

Aug 05, 2024

BUY
$25.26 - $29.6 $2.12 Million - $2.48 Million
83,754 Added 12.84%
735,962 $20.6 Million
Q1 2024

Apr 30, 2024

BUY
$25.89 - $29.73 $2.1 Million - $2.41 Million
81,168 Added 14.21%
652,208 $18.1 Million
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $513,323 - $666,751
-19,645 Reduced 3.33%
571,040 $16.4 Million
Q3 2023

Nov 02, 2023

SELL
$32.09 - $37.51 $702,418 - $821,056
-21,889 Reduced 3.57%
590,685 $19.6 Million
Q2 2023

Aug 09, 2023

BUY
$36.12 - $41.79 $1.65 Million - $1.91 Million
45,590 Added 8.04%
612,574 $22.5 Million
Q1 2023

May 10, 2023

SELL
$39.39 - $51.28 $26,706 - $34,767
-678 Reduced 0.12%
566,984 $23.1 Million
Q4 2022

Jan 18, 2023

SELL
$41.75 - $54.5 $1.98 Million - $2.58 Million
-47,311 Reduced 7.69%
567,662 $0
Q3 2022

Oct 14, 2022

SELL
$43.76 - $53.42 $4.28 Million - $5.22 Million
-97,728 Reduced 13.71%
614,973 $26.9 Million
Q2 2022

Jul 13, 2022

BUY
$46.53 - $55.17 $1.09 Million - $1.29 Million
23,378 Added 3.39%
712,701 $37.4 Million
Q1 2022

May 12, 2022

SELL
$45.75 - $56.69 $4.39 Million - $5.44 Million
-95,910 Reduced 12.21%
689,323 $35.7 Million
Q4 2021

Feb 10, 2022

SELL
$41.32 - $61.25 $4.45 Million - $6.6 Million
-107,703 Reduced 12.06%
785,233 $46.4 Million
Q3 2021

Oct 14, 2021

BUY
$39.25 - $50.42 $10.7 Million - $13.7 Million
271,678 Added 43.73%
892,936 $38.4 Million
Q2 2021

Aug 12, 2021

SELL
$35.91 - $40.68 $2.02 Million - $2.29 Million
-56,294 Reduced 8.31%
621,258 $24.3 Million
Q1 2021

Apr 22, 2021

BUY
$33.49 - $37.77 $1.75 Million - $1.98 Million
52,334 Added 8.37%
677,552 $24.5 Million
Q4 2020

Apr 01, 2021

BUY
$33.47 - $42.56 $3.8 Million - $4.83 Million
113,508 Added 22.18%
625,218 $23 Million
Q3 2020

Nov 02, 2020

BUY
$31.75 - $37.25 $1.01 Million - $1.19 Million
31,939 Added 6.66%
511,710 $18.3 Million
Q2 2020

Aug 17, 2020

BUY
$30.12 - $36.54 $1.57 Million - $1.91 Million
52,282 Added 12.23%
479,771 $15.7 Million
Q1 2020

May 12, 2020

SELL
$27.03 - $38.62 $683,426 - $976,468
-25,284 Reduced 5.58%
427,489 $14 Million
Q4 2019

Feb 10, 2020

SELL
$32.92 - $37.36 $1.47 Million - $1.66 Million
-44,522 Reduced 8.95%
452,773 $17.7 Million
Q3 2019

Nov 13, 2019

BUY
$32.49 - $42.13 $3.12 Million - $4.04 Million
95,884 Added 23.89%
497,295 $18 Million
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $196,770 - $220,927
5,321 Added 1.34%
401,411 $17.4 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $555,900 - $610,748
14,824 Added 3.89%
396,090 $16.7 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $883,463 - $1.01 Million
-22,965 Reduced 5.68%
381,266 $16.6 Million
Q3 2018

Nov 01, 2018

BUY
$34.47 - $41.81 $4.2 Million - $5.09 Million
121,806 Added 43.13%
404,231 $17.8 Million
Q2 2018

Aug 09, 2018

BUY
$32.98 - $35.16 $2.79 Million - $2.98 Million
84,746 Added 42.87%
282,425 $10.3 Million
Q1 2018

May 09, 2018

SELL
$31.91 - $37.02 $2.27 Million - $2.64 Million
-71,180 Reduced 26.47%
197,679 $7.02 Million
Q4 2017

Feb 07, 2018

SELL
$33.26 - $35.29 $5.06 Million - $5.37 Million
-152,223 Reduced 36.15%
268,859 $9.8 Million
Q3 2017

Nov 13, 2017

BUY
$31.0 - $34.15 $212,784 - $234,405
6,864 Added 1.66%
421,082 $15.2 Million
Q2 2017

Aug 10, 2017

BUY
N/A
414,218
414,218 $13.8 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $149B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.